Bausch Health looking to pay down more debt with senior offering

Bausch Health launched two $750 million offerings to repurchase $1.5 billion in aggregate principal on notes due in 2023.

What you should know:

1. Bausch split the notes so half will be due in 2028 and half will be due in 2029.

2. Bausch's outstanding 2023 senior notes are at 5.5 percent and 5.88 percent interest.

3. Bausch CEO Joseph Papa has made significant strides in recent years to pay down the company's large amount of debt. Bausch Health was previously known as Valeant Pharmaceuticals.

More articles on supply chain:
Healthcare experts discuss investor interest in orthopedics — 5 key points
University of Maryland children's medical device competition reveals 5 winners
RTI Surgical reports $9.1M net loss in Q1: 5 details

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers